We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanotechnology Employed to Detect Oral Cancer

By LabMedica International staff writers
Posted on 26 Aug 2010
A new test for oral cancer, which a dentist or oral surgeon could perform by simply using a brush to collect cells from a patient's mouth, has been developed. More...


The test, which could provide a rapid accurate diagnosis for lesions where there is a suspicion of oral cancer. The new test will involve removing cells with a brush, placing them on a chip, and inserting the chip into the analyzer, leading to a result in 8-10 minutes.

This new technology uses the latest techniques in microchip design, nanotechnology, micro-fluids, image analysis, pattern recognition, and biotechnology to shrink many of the main functions of a state-of-the-art clinical pathology laboratory onto a nano-biochip the size of a credit card.

The nano-biochips are disposable and slotted like a credit card into a battery-powered analyzer. A brush-biopsy sample is placed on the card and microfluidic circuits wash cells from the sample into the reaction chamber. The cells pass through minifluidic channels and come in contact with "biomarkers" that react only with specific types of diseased cells. The machine uses two light-emitting diodes (LED's), to light up various regions of the cells and cell compartments. Healthy and diseased cells can be distinguished from one another by the way they glow in response to the LEDs.

A team at the University of Sheffield (Sheffield, UK) begun carrying out clinical trials on patients at Charles Clifford Dental Hospital, (Sheffield, UK) for two years to perfect the technology and make it as sensitive as possible. If the trials confirm that the new technology is as effective as carrying out a biopsy then it could become a regular application at dentist surgeries in the future. The current procedure involves removing a small piece of tissue from the mouth and sending it to a pathologist. This is typically done at a hospital, can take a week or more, and involve extra visits for the patient.

Martin Thornhill, M.BB.S., B.D.S., Ph.D., Professor of Oral Medicine at Sheffield University, said, "This new affordable technology will significantly increase our ability to detect oral cancer in the future. With the new technology, a brush would be used to painlessly remove a few cells from the lining of the mouth that would be analyzed within minutes in the presence of the patient, so that the patient would know the result before leaving the clinic.”

Related Links:

University of Sheffield
Charles Clifford Dental Hospital




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.